Biosimilars as a Future, Promising Solution for Financial Toxicity: A Review with Emphasis on Bevacizumab

A biosimilar is a biochemical product like another already approved biologic agent, known as the reference agent. To be endorsed by the Food and Drug Administration (FDA), biosimilars must demonstrate that they are as safe and effective as their reference item, with no clinical distinction. Humanize...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleem, Tabinda, Qurashi, Hafiz, Jamali, Munira, Chan Gomez, Janet, Kanderi, Tejaswi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437115/
https://www.ncbi.nlm.nih.gov/pubmed/32832297
http://dx.doi.org/10.7759/cureus.9300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437115/
https://www.ncbi.nlm.nih.gov/pubmed/32832297
http://dx.doi.org/10.7759/cureus.9300

Ejemplares similares